The United States has delivered two million doses of the antimalarial drug hydroxychloroquine (HCQ) to Brazil to fight COVID-19, the White House said Sunday, though the drug has not yet been proven effective against the coronavirus.
“HCQ will be used as a prophylactic to help defend Brazil’s nurses, doctors, and healthcare professionals against the virus. It will also be used as a therapeutic to treat Brazilians who become infected,” a statement said.
It said the US would soon also send 1,000 ventilators to Brazil, the epicenter of South America’s outbreak with nearly 500,000 confirmed cases.
“We are also announcing a joint United States-Brazilian research effort that will include randomized controlled clinical trials,” it added.
On Saturday, Brazil registered a record 33,274 new cases of the novel coronavirus, its health ministry said, raising the total to 498,440 in a country with one of the world’s worst outbreaks.
The death toll in Brazil from COVID-19, the respiratory illness caused by the coronavirus, increased to 28,834, with 956 new deaths in the last 24 hours, the ministry said.
White House imposes travel ban on coronavirus-hit BrazilThe White House on Sunday broadened its travel ban against countries hard-hit by the coronavirus by denying admission to foreigners who have been in ... Coronavirus
Brazil breaks its coronavirus records after overtaking Russia as 2nd highest in casesBrazil’s coronavirus curve steepened further a day after it overtook Russia to become the country with the second-highest number of cases.The Latin ... Coronavirus
Coronavirus: US hospitals cut back use of hydroxychloroquine touted by TrumpUS hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug touted by President Donald Trump as a COVID-19 ... Coronavirus